摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(Ethoxymethyl)-4-methylmorpholine

中文名称
——
中文别名
——
英文名称
2-(Ethoxymethyl)-4-methylmorpholine
英文别名
2-(ethoxymethyl)-4-methylmorpholine
2-(Ethoxymethyl)-4-methylmorpholine化学式
CAS
——
化学式
C8H17NO2
mdl
——
分子量
159.23
InChiKey
PTLOKNSSAWBDPE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    11
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    21.7
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • [EN] N-(ARYLALKYL)-N'-PYRAZOLYL-UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS<br/>[FR] COMPOSÉS DE N-(ARYLALKYLE)-N'-PYRAZOLYLE-URÉE, DE THIOURÉE, DE GUANIDINE ET DE CYANOGUANIDINE EN TANT QU'INHIBITEURS DE LA KINASE TRKA
    申请人:ARRAY BIOPHARMA INC
    公开号:WO2014078331A1
    公开(公告)日:2014-05-22
    Compounds of Formula I or stereoisomers, tautomers, or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ring A, Ring C, X, Ra, Rb, Rc, Rd and n are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation/inflammatory diseases, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis or pelvic pain syndrome.
    公式I的化合物或立体异构体、互变异构体、或药用可接受的盐、溶剂化物或前药,其中环A、环C、X、Ra、Rb、Rc、Rd和n如本文所述定义,是TrkA激酶的抑制剂,可用于治疗可以用TrkA激酶抑制剂治疗的疾病,如疼痛、癌症、炎症/炎症性疾病、神经退行性疾病、某些传染病、舍格伦综合症、子宫内膜异位症、糖尿病周围神经病变、前列腺炎或骨盆疼痛综合征。
  • [EN] N-(MONOCYCLIC ARYL),N'-PYRAZOLYL-UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS<br/>[FR] COMPOSÉS DE N-ARYLE MONOCYCLIQUES, N'-PYRAZOLYL-URÉE, THIOURÉE, GUANIDINE ET CYANOGUANIDINE UTILES COMME INHIBITEURS DE TRKA KINASE
    申请人:ARRAY BIOPHARMA INC
    公开号:WO2014078325A1
    公开(公告)日:2014-05-22
    Compounds of Formula (I) or stereoisomers, tautomers, or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ring A, Ring C and X are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation/inflammatory diseases, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis or pelvic pain syndrome.
    化合物的公式(I)或其立体异构体、互变异构体、或其药学上可接受的盐、溶剂合物或前药,其中环A、环C和X如本文所定义,是TrkA激酶的抑制剂,并且在治疗可以用TrkA激酶抑制剂治疗的疾病中具有用处,如疼痛、癌症、炎症/炎症性疾病、神经退行性疾病、某些传染病、干燥综合征、子宫内膜异位症、糖尿病周围神经病变、前列腺炎或盆腔疼痛综合征。
  • 1,7-DIAZACARBAZOLES AND METHODS OF USE
    申请人:Genentech, Inc.
    公开号:US20140171407A1
    公开(公告)日:2014-06-19
    The invention relates to 1,7-diazacarbazole compounds of Formula (I), (I-a) and (I-b) which are useful as kinase inhibitors, more specifically useful as checkpoint kinase 1 (chk1) inhibitors, thus useful as cancer therapeutics. The invention also relates to compositions, more specifically pharmaceutical compositions comprising these compounds and methods of using the same to treat various forms of cancer and hyperproliferative disorders, as well as methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.
    该发明涉及化合物公式为(I)、(I-a)和(I-b)的1,7-二氮杂咔唑化合物,其作为激酶抑制剂具有用途,更具体地作为检查点激酶1(chk1)抑制剂,因此具有作为癌症治疗药物的用途。该发明还涉及包括这些化合物的组合物,更具体地是包括这些化合物的制药组合物以及使用它们治疗各种癌症和高增殖性疾病的方法,以及使用这些化合物进行哺乳动物细胞的体外、原位和体内诊断或治疗,或相关病理条件的方法。
  • [EN] POLYMER COMPOSITIONS, FILMS, GELS, AND FOAMS CONTAINING SULFONYLIMIDE SALTS, AND ELECTRONIC DEVICES CONTAINING SUCH FILMS, GELS, AND FOAMS<br/>[FR] COMPOSITIONS, FILMS, GELS, ET MOUSSES POLYMÈRES CONTENANT DES SELS DE SULFONYLIMIDE, ET DISPOSITIFS ÉLECTRONIQUES CONTENANT LESDITS FILMS, GELS, ET MOUSSES
    申请人:RHODIA OPERATIONS
    公开号:WO2015088999A1
    公开(公告)日:2015-06-18
    Described herein are polymer films, polymer gels, and polymer foams each containing electrically conductive polymers and salts comprising sulfonylimide anions. The polymer films, polymer gels, and polymer foams are each useful as components of electronic devices.
  • [EN] POLYMER FILMS, GELS, AND FOAMS CONTAINING ELECTRICALLY CONDUCTIVE PATTERNS, AND ELECTRONIC DEVICES CONTAINING SUCH FILMS, GELS, AND FOAMS<br/>[FR] FILMS, GELS ET MOUSSES POLYMÈRES CONTENANT DES MOTIFS ÉLECTRIQUEMENT CONDUCTEURS ET DISPOSITIFS ÉLECTRONIQUES CONTENANT CES FILMS, GELS ET MOUSSES
    申请人:RHODIA OPERATIONS
    公开号:WO2015089001A1
    公开(公告)日:2015-06-18
    Polymer films, polymer gels, and polymer foams each containing electrically conductive patterns comprising an ionic liquid, a salt comprising sulfonylimide anions, or a combination thereof. The polymer films, polymer gels, and polymer foams each containing electrically conductive patterns comprising an ionic liquid, a salt comprising sulfonylimide anions, or a combination thereof, are useful as components of electronic devices.
查看更多

同类化合物

(4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (2-肟基-氰基乙酸乙酯)-N,N-二甲基-吗啉基脲六氟磷酸酯 鲸蜡基乙基吗啉氮鎓乙基硫酸盐 马啉乙磺酸钾 预分散OTOS-80 顺式4-(氮杂环丁烷-3-基)-2,2-二甲基吗啉 顺式-N-亚硝基-2,6-二甲基吗啉 顺式-3,5-二甲基吗啉 顺-2,6-二甲基-4-(4-硝基苯基)吗啉 非屈酯 雷奈佐利二聚体 阿瑞杂质9 阿瑞吡坦磷的二卞酯 阿瑞吡坦杂质 阿瑞吡坦杂质 阿瑞吡坦 阿瑞吡坦 阿瑞匹坦非对映异构体2R3R1R 阿瑞匹坦杂质A异构体 阿瑞匹坦杂质54 阿瑞匹坦-M3代谢物 钾[2 - (吗啉- 4 -基)乙氧基]甲基三氟硼酸 邻苯二甲酸单吗啉 调节安 试剂2-(4-Morpholino)ethyl2-bromoisobutyrate 茂硫磷 苯甲腈,2-(4-吗啉基)-5-[1,4,5,6-四氢-4-(羟甲基)-6-羰基-3-哒嗪基]- 苯甲曲秦 苯甲吗啉酮 苯基2-(2-苯基吗啉-4-基)乙基碳酸酯盐酸盐 苯二甲吗啉一氢酒石酸盐 苯二甲吗啉 苯乙酮 O-(吗啉基羰基甲基)肟 芬美曲秦 芬布酯盐酸盐 芬布酯 脾脏酪氨酸激酶(SYK)抑制剂 脱氯利伐沙班 脱氟雷奈佐利 羟基1-(3-氯苯基)-2-[(1,1-二甲基乙基)氨基]-1-丙酮盐酸盐 福沙匹坦苄酯 福沙匹坦杂质26 福曲他明 碘化N-甲基丙基吗啉 碘化N-甲基,乙基吗啉 硝酸吗啉 盐酸吗啡啉-D8 甲基吗啉-2-羧酸甲酯2,2,2-三氟乙酸盐 甲基N-[3-(乙酰基氨基)-4-[(2-氰基-4,6-二硝基苯基)偶氮]苯基]-N-乙基-&#x3B2-丙氨酸酸酯 甲基4-吗啉二硫代甲酸酯